Arrowhead Pharmaceuticals Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Arrowhead Pharmaceuticals Inc with three other companies in this sector in the United States: Applied Genetic Technologies Corp (2019 sales of $41.69 million of which 100% was Gene therapy), Predictive Technology Group Inc ($43.49 million of which 100% was Regenerative medicine products and HCT/P), and Bioanalytical Systems, Inc. ($43.62 million ).

Sales Analysis. Sales increased substantially in 2019: During the year ended September of 2019, sales at Arrowhead Pharmaceuticals Inc were $168.80 million. This is an increase of 945.7% versus 2018, when the company's sales were $16.14 million.